Article
Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment.
Cancer cytopathology - 1 Jun 2014
Proietti Agnese, Alì Greta, Pelliccioni Serena, Lupi Cristiana, Sensi Elisa, Boldrini Laura, Servadio Adele, Chella Antonio, Ribechini Alessandro, Cappuzzo Federico, Miccoli Mario, Fontanini Gabriella
Abstract excerpt
BACKGROUND: Anaplastic lymphoma kinase (ALK) gene rearrangements are detected in approximately 5% of cases of non-small cell lung cancer (NSCLC). Patients who are positive for ALK rearrangements may be successfully treated with the ALK inhibitor crizotinib. Because advanced-stage lung cancers are not suitable for surgical resection, approximately 70% of patients are diagnosed via preoperative specimens. In the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
